Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...

Adding functional imaging to structural imaging of patients with ventricular tachycardia (VT) has the potential to improve current VT ablation strategies, according to new research published in the ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...

Introduction: Functional testing by stress myocardial perfusion imaging (MPI) and anatomical imaging by coronary computed tomography angiography (CCTA) are often used interchangeably in the initial ...

Left: primary/scatter window SPECT reconstructions, plus synthetic and CT-based attenuation maps. Right: SPECT reconstructed images corrected using CT-based attenuation maps, synthetic attenuation ...

To lead the integration and growth of the SPECT business, SHINE has named Michael Rossi as CEO of SHINE SPECT USA, LLC.